Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2013 | 12-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,990 | N/A | 0 | 0 | N/A |
| Depreciation Amortization | 20 | N/A | 0 | 0 | N/A |
| Other Working Capital | -1,310 | N/A | 0 | 0 | N/A |
| Other Operating Activity | 1,120 | 0 | -7,060 | 0 | 0 |
| Operating Cash Flow | $-8,160 | $N/A | $-7,060 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | -20 | 0 | N/A |
| Investing Cash Flow | $-20 | $N/A | $-20 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 16,000 | 0 | 3,740 | 0 | 0 |
| Financing Cash Flow | $16,000 | $N/A | $3,740 | $0 | $N/A |
| Exchange Rate Effect | 110 | N/A | 40 | 0 | N/A |
| Beginning Cash Position | 5,780 | N/A | 9,120 | 0 | N/A |
| End Cash Position | 13,710 | N/A | 5,820 | 0 | N/A |
| Net Cash Flow | $7,920 | $N/A | $-3,300 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,160 | N/A | -7,060 | 0 | N/A |
| Free Cash Flow | -8,160 | 0 | -7,060 | 0 | 0 |